baber/WOPTO huggingface dataset:
Patent NO-892015-D0 (NO)
Inventor: ZOUBEK EUGEN
IPC: A61K35/26
Filed: 1989-05-19
Abstract: The invention relates to a medicament in the form of a lyophilisate produced from a total extract from Peyer's patches, preferably in homoeopathic dilution. It can be used advantageously for the improvement of the humoral defence system.
Patent NO-902717-D0 (NO)
Inventor: WIESSLER MANFRED
IPC: C07H11/04
Filed: 1990-06-19
Abstract: The invention concerns a process for preparing glycoconjugates of phosphoramides of general formula (1) and (1a) in which the sugar is linked to the phosphoramide mustard function or the ifosfamide mustard function preferably in the 1 position and R1 and R2 are identical or different and may denote hydrogen, lower C1-C4 alkyl or C1-C6 alkyl halide and the sugar may be present as mono-, di- or polysaccharides in all existing isomeric and enantiomeric forms by conjugating protected bromine sugar in a manner known per se with the corresponding phosphorus compounds and releasing it from the protective groups. Also described are D-glycopyranosyl-N,N'-di(2-chloroethyl)-phosphoric acid diamides and the use of the compounds as antitumoral agents.
Patent NO-921407-D0 (NO)
Inventor: HOEOEK MAGNUS
IPC: A61P17/00
Filed: 1992-04-09
Abstract: The present invention relates to a fibronecting binding peptide having the structure R'-PSYQFGGHNS VDFEEDT-R<2>, wherein R' is hydrogen of K or DK, and R<2> is hydroxy, L, LP, or LPK.
Patent NO-924985-D0 (NO)
Inventor: KRENNING ERIC PAUL
IPC: A61K9/64
Filed: 1992-12-22
Abstract: Disclosed are sustained release dosage forms of liothyronine, in combination with normal or sustained release of thyroxine in a molar ratio of about 1 to 50 : 1, especially 5 to 20 : 1, useful in thyroid hormone replacement therapy. Surprisingly, it is found that by incorporating liothyronine and optionally thyroxine into a prolonged action dosage form in the described ratios, that the side effects associated with thyroid hormone replacement therapy are greatly reduced or eliminated. The preparation can be a dosage form containing salts of both thyroxine and liothyronine which release in a sustained manner. The preparations will typically contain 5 to 25 mu g of liothryronine. Also disclosed are processes of manufacturing the pharmaceutical preparations. The compositions are useful in treating disease states such as hypothyroidism, hyperthyroidism (in combination with thyrostatic drugs), so-called "TSH" suppressive therapy, and depression.
Patent NO-931757-D0 (NO)
Inventor: DENTON ROBERT
IPC: F16J15/32
Filed: 1993-05-14
Abstract: A dynamic O-ring seal for retaining the lubrication around a rock bit bearing for drilling subterranean formations has a composition comprising 100 parts by weight highly-saturated nitrile elastomer, furnace black in the range of from 40 to 70 parts by weight, peroxide curing agent in the range of from 7 to 10 parts by weight, graphite in the range of from 10 to 20 parts by weight, zinc oxide or magnesium oxide in the range of from 4 to 7 parts by weight, stearic acid in the range of from 0.5 to 2 parts by weight, and sufficient plasticizer to provide a Shore hardness no more than A 80. <IMAGE>
Patent NO-931858-D0 (NO)
Inventor: SATO HACHIRO
IPC: C02F11/12
Filed: 1993-05-21
Abstract: In a method of dewatering sludge wastes discharged from a factory such as pulp factory, sludge wastes are first dewatered by a preliminary dewatering device such as a pre-thickener of a rotary screen type, a sludge discharged from the preliminary dewatering device is then supplied to a main dewatering device such as a screw press. Waste liquids discharged from the preliminary and main dewatering devices are supplied to an agglutinating reaction tank together with a macromolecular agglutinating reagent and agglutinated substances in the agglutinating reaction tank are treated by the main dewatering device. The agglutinated substances formed on the bottom surface of the agglutinating reaction tank may be treated by a different main dewatering device than said main dewatering device. A necessary amount of the macromolecular agglutinating reagent to be supplied to the agglutinating reaction tank can be reduced, while the dewatering efficiency is not deteriorated. <IMAGE>
Patent NO-933140-D0 (NO)
Inventor: FRANZ HELMUT
IPC: A61P27/02
Filed: 1993-09-03
Abstract: The invention relates to an ophthalmic solution for topical application to the eye to reduce an elevated intraocular pressure, containing an amount, which is effective for reducing the intraocular pressure, of a polyhydroxy alcohol such as sorbitol, mannitol, inositol or xylitol or mixtures thereof in a vehicle which is tolerated by the eye, the use thereof and the preparation thereof.
Patent NO-934585-D0 (NO)
IPC: C08F10/00
Filed: 1993-12-13
Abstract: PCT No. PCT/NO94/00201 Sec. 371 Date Jul. 24, 1996 Sec. 102(e) Date Jul. 24, 1996 PCT Filed Dec. 12, 1994 PCT Pub. No. WO95/16517 PCT Pub. Date Jun. 22, 1995An improved process for the production of polyolefins in an autoclave reactor having several reaction zones operated at a pressure of 100 to 300 MPa and a temperature of 100 to 300 DEG  C. is disclosed. Dunng operation, temperatures are measured continuously inside the autoclave reactor at specific points distributed along the reactor length, each of said measured temperatures is compared with a corresponding preset temperature and the detected deviation between each pair of preset and measured temperatures is used in regulating the amount of monomer and initiator fed into the autoclave through several feed inlets distributed along the reactor length, in order to minimize the temperature deviations and thus obtain an improved control of the polymerization process.
Patent NO-934801-D0 (NO)
Inventor: LINSLEY PETER S
IPC: G01N33/53
Filed: 1993-12-23
Abstract: The invention identifies the CTLA4 receptor as a ligand for the B7 antigen. The complete amino acid sequence encoding human CTLA4 receptor gene is provided. Methods are provided for expressing CTLA4 as an immunoglobulin fusion protein, for preparing hybrid CTLA4 fusion proteins, and for using the soluble fusion proteins, fragments and derivatives thereof, including monoclonal antibodies reactive with B7 and CTLA4, to regulate T cell interactions and immune responses mediated by such interactions.
Patent NO-941402-D0 (NO)
Inventor: HOOGENBOOM CHRISTOPHER L
IPC: H03M7/30
Filed: 1994-04-18
Abstract: A method and apparatus (10) are provided for inverse transforming a matrix of discrete cosine transform (DCT) coefficients. The DCT coefficients are processed at least two bits at a time to obtain the vector dot products thereof with a DCT kernel matrix. A matrix of the vector dot products is transposed (112) to obtain a transposed matrix of dot product elements. The dot product elements of the transposed matrix are processed at least two bits at a time to obtain the vector dot products thereof with the DCT kernel matrix. The resultant dot products are interleaved into a proper order and buffered in a series of output registers (118). Further efficiencies are achieved by implementing a post-add stage (104) of an IDCT flowgraph prior to the output registers. <IMAGE>
Patent NO-943570-D0 (NO)
Inventor: EBY ERIC
IPC: G02B5/26
Filed: 1994-09-26
Abstract: The present invention provides a coating for a transparent substrate which exhibits a "neutral" color through a wide range of angles of incidence of light. The coating employs a base coat adjacent the transparent substrate having a thickness of no more than about 275 Å and may include two reflective metal layers having an intermediate layer of an anti-reflective metal oxide therebetween and an outer anti-reflective layer of metal oxide over the second reflective metal layer. If so desired, the coating of the invention may include an abrasive-resistant overcoat as its outermost layer. This overcoat is desirably formed of an abrasive-resistant metal oxide, such as zinc oxide applied at a thickness which does not significantly affect the optical properties of said coated substrate.
Patent NO-954505-D0 (NO)
Inventor: BENENOWSKI SEBASTIAN
IPC: E01B7/12
Filed: 1995-11-09
Abstract: The proposal is for a crossing nose (10) arranged substantially at a distance from a substrate between positions on wing rails (12, 14).
Patent NO-954813-D0 (NO)
Inventor: BOWDEN MARTIN CHARLES
IPC: C07C/
Filed: 1995-11-27
Abstract: A process for the preparation of a lower alkyl ester of 3-(2-chloro-3,3,3-trifluoroprop-1-en-1-yl)- 2,2-dimethylcyclopropane carboxylic acid where lower alkyl means alkyl of up to four carbon atoms which comprises the steps of (a) reacting a compound of formula: CF3-CXCl-CH(OH)-CH=C(CH3)2 wherein X is chloro or bromo, with a tri-lower-alkyl orthoacetate containing up to four carbon atoms in each alkyl group in the presence of at least a catalytic amount of an active clay at an elevated temperature for a sufficient time to obtain a compound of formula: CF3-CXCl-CH=CH-C(CH3)2-CH2CO2R wherein R is an alkyl group containing up to four carbon atoms, and (b) treating said compound of formula (III) with at least one molar equivalent of a base to obtain said alkyl ester of 3-(2-chloro-3,3,3-trifluoroprop-1-en-1-yl)-2,2-dimethylcyclopropane carboxylic acid.
Patent NO-962153-D0 (NO)
Inventor: PRUDHOE GORDON
IPC: A61K31/167
Filed: 1996-05-28
Abstract: PCT No. PCT/EP95/00719 Sec. 371 Date Jun. 4, 1996 Sec. 102(e) Date Jun. 4, 1996 PCT Filed Feb. 27, 1995 PCT Pub. No. WO95/22974 PCT Pub. Date Aug. 31, 1995The present invention is concerned with a film coated tablet comprising as active ingredients the analgesic agent paracetamol and the antiemetic agent domperidone, and with a process of preparing such tablets.
Patent NO-980311-D0 (NO)
Inventor: EHNSTROEM LARS
IPC: B08B9/00
Filed: 1998-01-23
Abstract: PCT No. PCT/SE96/00971 Sec. 371 Date Mar. 11, 1998 Sec. 102(e) Date Mar. 11, 1998 PCT Filed Jul. 24, 1996 PCT Pub. No. WO97/04874 PCT Pub. Date Feb. 13, 1997A device and a process for centrifugal separation of solid particles from a liquid is disclosed. The device comprises a vessel rotatable around a vertical axis. The vessel has a separation zone with separation surface elements. The separation surface elements are formed by a plurality of adjacent, axially oriented tubular elements or channels open at both ends. The process is characterized in that the liquid is caused to flow with essentially laminar flow through a plurality of axially oriented, parallel channels and is subjected to a g-number, preferably less than 100, in order to centrifugally deposit the particles on the channel walls.
Patent NO-980502-D0 (NO)
Inventor: LEBOUCHER ALAIN
IPC: H01R39/42
Filed: 1998-02-05
Abstract: The circuit has a number of conducting brushes (42) which are positioned on individual carriers (47) on one or more carrier rods (48) regularly around the central axis (XX) of the rotor. Triggers (51) set the brushes angularly between making contact with a rotor ring (30) and being spaced from it. Each trigger is operated by a control finger comprising a rod (52) parallel to the carrier rods. Each rod is on an arm (54) which stands radially proud from a rotating disc (53) which is supported by a brush carrier rod. The fixed electromagnets are supplied by a control circuit simultaneously and their cores are connected to the fingers by a hinge (57).
Patent NO-992214-D0 (NO)
Inventor: ODDS FRANK CHRISTOPHER
IPC: A61K31/14
Filed: 1999-05-06
Abstract: The invention relates to compositions such as body and hair cleansing products, in particular shampoos, comprising one or more antifungals inhibiting fungal ergosterol biosynthesis as a first active ingredient and 10 @ -undecen-3-oyl-aminopropyl trimethylammonium methylsulfate as a second active ingredient.
Patent NO-995475-D0 (NO)
Inventor: EMERY STEPHEN CHARLES
IPC: C07K16/30
Filed: 1999-11-09
Abstract: The invention provides a gene construct encoding a cell targeting moiety and a heterologous prodrug activating enzyme for use as a medicament in a mammalian host wherein the gene construct is capable of expressing the cell targeting moiety and enzyme as a conjugate within a target cell in the mammalian host and wherein the conjugate is directed to leave the cell thereafter for selective localisation at a cell surface antigen recognised by the cell targeting moiety.
Patent GB-0120552-D0 (GB)
Title: Cryogenic crystallisation of solid fats
IPC: C11B15/00
Filed: 2001-08-23
Abstract: A method of processing the solid fat phase of a food product which comprises or contains a dispersion of solid fat in an oil phase, the method comprising bringing the solid fat phase with a minimal amount of the oil phase in a liquid state to a cooling device and there cooling the product to effect fat crystallisation as quickly as possible.
Patent GB-0226384-D0 (GB)
Title: A method for forwarding and storing session packets according to preset and/or dynamic rules
IPC: H04M7/00
Filed: 2002-11-12
Abstract: A system and method for recording and/or monitoring data by forwarding it, with or without analyzing or otherwise filtering the data itself are provided. According to embodiments of the invention, the system and method are operative over IP networks. According to an embodiment of the invention, there is provided a system and method for forwarding data according to at least one characteristic of the data, such as the session's metadata for example, without analyzing or otherwise filtering the data itself. According to another embodiment of the invention, before the data is forwarded to the recording device, pre-processing algorithms are performed according to a system preset or according to one or more rules.
Patent GB-0329620-D0 (GB)
Title: EP2 receptor agonists
IPC: A61K31/557
Filed: 2003-12-22
Abstract: A compound selected from one of the following: or a salt, solvate, chemically protected form or prodrug thereof, and its use in treating conditions alleviated by agonism of an EP<SUB>2 </SUB>receptor.
Patent GB-0405298-D0 (GB)
Title: Gate operator with speed and torque control
IPC: E05F15/20
Filed: 2004-03-09
Abstract: A method and system for controlling the speed of security gate depending on its length is disclosed. It includes a system for determining the length of a gate that the system is working with and which automatically sets the speed of movement of the gate based on length. The system works automatically so that human intervention is not necessary to set the optimal speed once installed.
Patent GB-0410179-D0 (GB)
Title: Searching electronic mail and messages
IPC: H04L29/08
Filed: 2004-05-07
Abstract: A method for recovering information from electronic communications, including conveying an indication of a topic of interest, from a searcher on the topic, to a computing system storing a first set of the communications of a first communicator, and searching within the first set, in response to the indication, to identify one or more first communications on the topic of interest, thereby defining a primary sub-set of communications. The method further includes determining identities of one or more second communicators who participated in the primary sub-set, searching within a second set of the communications of the one or more second communicators, in response to the indication, to identify one or more second communications on the topic of interest, thereby defining a secondary sub-set of communications, the second set of the communications being stored in the computing system, and conveying information from the searches to the searcher.
Patent GB-0500229-D0 (GB)
Title: Trading card
IPC: A63F9/24
Filed: 2005-01-07
Abstract: Trading cards (1, 2) each include part (17, 18) of a circuit. When the trading cards are inserted into a game card (3), a circuit is completed. Depending on the circuit, one of four light emitting diodes (291, 292, 293, 294) on the game card is lit. No semiconductor chip is required in the card.
Patent GB-0521554-D0 (GB)
Title: Control of mammary cell number
IPC: C07K14/47
Filed: 2005-10-21
Abstract: The present invention provides new methods and uses of peptides in effecting a reduction in mammary cell number. The discovery that these peptides reduce mammary cell number further enables the use of these peptides in the treatment of cancer where the peptides can be used to reduce cell number and accordingly reduce or prevent tumour development. The inventor has further shown that the peptides have specific utility in the treatment of breast cancer.
Patent GB-8415820-D0 (GB)
Title: Terphenyl derivatives
IPC: A61K31/09
Filed: 1984-06-21
Abstract: This invention provides for certain novel terphenyl derivatives, their pharmaceutical formulations, and a method of treating pain, fever, thrombosis, inflammation, and arthritis.
Patent GB-8516683-D0 (GB)
Title: Dashpot
IPC: F17C13/04
Filed: 1985-07-02
Abstract: A sealing valve either blocks or releases the gas held under pressure in a gas cylinder, for example. When the sealing valve is opened, the flow path is opened and a pressure impact travels to the equipment connected downstream of the valve and can cause damage thereto. The attenuator valve of the invention is disposed in the pressure-gas conduit between the pressure-gas source and the sealing valve and prevents this kind of an impact from occurring. Since the attenuator valve of the invention is controlled exclusively by pressure, it can be mounted at any location in the pressure-gas conduit. The attenuator valve of the invention includes a housing and a valve body mounted in the housing which shuts off the pressure-gas conduit with the aid of a closure cone which is held in sealing contact to a conical valve recess by means of a spring. The pressurized gas in the cylinder is present above the valve body via an alternate path. When the pressure of the gas beneath the valve body drops, this pressurized gas above the valve body causes the same to be lifted from its conical valve recess against the force of the spring thereby causing a slowed flow of gas which is free of impact to pass through the sealing valve to the equipment.
Patent GB-8626767-D0 (GB)
Title: Assays
IPC: G01N33/543
Filed: 1986-11-10
Abstract: An immunoassay method comprises the steps of contacting a sample suspected of containing an analyte with a reagent comprising an antibody having a plurality of dissimilar specific binding sites of which at least one is specific for the analyte and of which at least one other is specific for a labelling compound; contacting the sample with a solid phase to which is bound molecules of the analyte and/or a cross-reactive analogue of the analyte; separating the sample from the solid phase; and analysing either or both of the separated sample and the solid phase for the presence of the labelling compound. The solid phase can be in a column, and preferably the analyte is hCG and the labelling compound is alkaline phosphatase enzyme.
Patent GB-8728775-D0 (GB)
Title: Method & device for paint brush preservation & storage
IPC: B65D81/22
Filed: 1987-12-09
Abstract: A paint brush cleaning or storage device is provided in the form of a sealed sachet (1) containing a predetmined quantity of a brush preserving or cleaning liquid (3), which sachet can be opened, for example by cutting along one edge or by means of a tear-off strip, to permit the brush head (5,6) to be inserted therein immediately after use either to prevent the brush drying out and keeping it ready for reuse, or to clean the brush. Preferably the sachet is of deformable foil which can be wrapped around (7) the brush handle (4) to reseal the sachet.
Patent GB-8827809-D0 (GB)
Title: Pivoting valve mechanism
IPC: G01F11/32
Filed: 1988-11-29
Abstract: The invention provides a device for dispensing known aliquots of a fluid, notably a spirit or other beverage, which device comprises a fluid receiving chamber 3 having a fluid inlet port 5 and a fluid outlet port 6 and valve means 7,8,9,10 located at least in part within the chamber 3 for regulating the flow of fluid into and out of the chamber, characterised in that the valve means comprises obturator members 7,8 adapted to engage with and seal the inlet and outlet ports 5,6 to the chamber 3, said obturator members 7,8 being carried by a spring member 9,10 adapted to urge the obturator members 7,8 axially relative to aone another and into sealing engagement with the said inlet and outlet ports 5,6; and a valve operating means 11,12,13,20,21 adapted to overcome the effect of said spring member 9,10 and to move only a selected one of said obturator members 7,8 out of sealing engagement with its said port 5,6 at a time.
Patent GB-8917070-D0 (GB)
Title: Dispensing package
IPC: B65D47/20
Filed: 1989-07-26
Abstract: A package for dispensing premeasured quantities of a granular or powdered fluent material, the package comprising:   a) an elongate container (1) having sloping shoulders (5) and an open, upstanding neck (3), the container being surmounted by b) an overcap (2) having a ceiling (7), a dispensing orifice (10), an outer skirt (8), and an inner skirt (9) separate from or partially contiguous with the outer skirt and which surrounds the container neck (3) in overlapping, laterally-spaced relationship thereto, wherein the ceiling (7), outer and inner skirts (8,9), neck (3) and sloping shoulders (5) together cooperate to define a preliminary measuring section (17) above the container neck bounded by the ceiling (7) and the inner skirt (8), a main measuring section (18) bounded by the sloping shoulders (5) and the outer skirt (8), and an outlet passage (19) located between the inner and outer skirts (8,9) and communicating with the dispensing orifice (10), and wherein the lateral separation of the inner skirt (9) and container neck (3) is such as to constrict flow of material from the preliminary measuring section to the main measuring section during inversion of the package and to permit such flow on restoring the package to its normal upright position.
Patent GB-9206679-D0 (GB)
Title: Mobile terminals and mobile communication networks involving such terminals
IPC: H04W8/24
Filed: 1992-03-27
Abstract: A communications network has a switching network including a mobile switching centre (MSC 10) which communicates, e.g. by radio telephony, with mobile equipment (ME 12), such as a mobile telephone. The mobile equipment contains a subscriber identity module (SIM 20) which stores data for controlling the operation of, and the facilities available to the user, of the mobile equipment (12). In accordance with the present invention, the switching network transmits updating signals to the mobile equipment (12) which alter the data stored in the subscriber identity module (20), and hence alter the operation on facilities available. <IMAGE>
Patent GB-9310203-D0 (GB)
Title: Compositions of new matter
IPC: A01N31/08
Filed: 1993-05-18
Abstract: Herbicides derived from 2-cyano-1,3-diones have the formula: <CHEM> in which R, R<1>, R<2>, R<3>, R<4> and n are as defined in the description. The compounds are intended for use against dicotyledonous and monocotyledonous weeds by pre- and/or post emergence application.